Differential censoring in overall survival in phase 3 oncology clinical trials
- DOI
- 10.1093/jnci/djaf378
- Published
- 2025-12-30
- Container
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/jnci/djaf378,
title = {Differential censoring in overall survival in phase 3 oncology clinical trials},
author = {Eric J Hsu and Alexander D Sherry and Timothy A Lin and Joseph Abi Jaoude and Ramez Kouzy and Zachary McCaw and Tomer Meirson and Pavlos Msaouel and Ethan B Ludmir},
year = {2025},
journal = {JNCI: Journal of the National Cancer Institute},
doi = {10.1093/jnci/djaf378},
url = {https://doi.org/10.1093/jnci/djaf378}
}RIS
TY - JOUR TI - Differential censoring in overall survival in phase 3 oncology clinical trials AU - Eric J Hsu AU - Alexander D Sherry AU - Timothy A Lin AU - Joseph Abi Jaoude AU - Ramez Kouzy AU - Zachary McCaw AU - Tomer Meirson AU - Pavlos Msaouel AU - Ethan B Ludmir PY - 2025 JO - JNCI: Journal of the National Cancer Institute DO - 10.1093/jnci/djaf378 UR - https://doi.org/10.1093/jnci/djaf378 ER -
APA
Hsu, E. J., Sherry, A. D., Lin, T. A., Jaoude, J. A., Kouzy, R., McCaw, Z., Meirson, T., Msaouel, P., & Ludmir, E. B. (2025). Differential censoring in overall survival in phase 3 oncology clinical trials. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf378
Source records
- crossref · retrieved 2026-09-26T03:23:04.809Z